| |
| |
|
| Insider
Information: |
Greene Gabrielle E |
| Relationship: |
Director |
| City: |
Austin |
| State: |
TX |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
8 |
|
| Direct
Shares |
191,878 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$7,629,096 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
191,878 |
|
|
| Total
Value |
$7,629,096 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
1
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
-1.0
|
| Percentage
Gain/Loss : |
 126.5%
|
 -74.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Whole Foods Market Inc |
WFM |
Director |
2017-08-28 |
0 |
2004-08-05 |
0 |
Premium* |
|
|
IndyMac Bancorp Inc |
IDMCQ |
Director, IndyMac Bank... |
2008-03-19 |
4,443 |
2007-01-23 |
0 |
Premium* |
|
|
Stage Stores Inc |
SSI |
Director |
2014-06-10 |
26,729 |
|
0 |
Premium* |
|
|
Brixmor Property Group Inc. |
BRX |
Director |
2021-06-01 |
37,161 |
|
0 |
Premium* |
|
|
MasterCard Inc A |
MA |
Director |
2023-06-27 |
4,333 |
2018-12-03 |
0 |
Premium* |
|
|
Cerevel Therapeutics Holdings, I... |
CERE |
Director |
2023-06-07 |
47,853 |
|
0 |
Premium* |
|
|
Warby Parker Inc. |
WRBY |
Director |
2023-06-08 |
69,231 |
|
0 |
Premium* |
|
|
Eli Lilly & Co |
LLY |
Director |
2024-04-15 |
2,128 |
2021-11-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
101 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BRX |
Brixmor Property Group In... |
Director |
– • – |
2015-06-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,000 |
|
- |
|
| BRX |
Brixmor Property Group In... |
Director |
– • – |
2016-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
10,000 |
0 |
- |
|
| BRX |
Brixmor Property Group In... |
Director |
– • – |
2017-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
15,000 |
0 |
- |
|
| BRX |
Brixmor Property Group In... |
Director |
– • – |
2017-12-06 |
4 |
B |
$17.71 |
$24,989 |
D/D |
1,411 |
16,411 |
2.39 |
- |
|
| BRX |
Brixmor Property Group In... |
Director |
– • – |
2018-03-09 |
4 |
B |
$15.52 |
$11,640 |
D/D |
750 |
17,161 |
2.39 |
- |
|
| BRX |
Brixmor Property Group In... |
Director |
– • – |
2018-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
22,161 |
0 |
- |
|
| BRX |
Brixmor Property Group In... |
Director |
– • – |
2019-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
27,161 |
0 |
- |
|
| BRX |
Brixmor Property Group In... |
Director |
– • – |
2020-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
32,161 |
0 |
- |
|
| BRX |
Brixmor Property Group In... |
Director |
– • – |
2021-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
37,161 |
0 |
- |
|
| CERE |
Cerevel Therapeutics Hold... |
Director |
– • – |
2020-10-27 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
14,270 |
|
% |
|
| CERE |
Cerevel Therapeutics Hold... |
Director |
– • – |
2021-06-17 |
4 |
B |
$13.06 |
$275,357 |
D/D |
21,084 |
35,354 |
2.39 |
% |
|
| CERE |
Cerevel Therapeutics Hold... |
Director |
– • – |
2021-06-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,270 |
49,624 |
0 |
- |
|
| CERE |
Cerevel Therapeutics Hold... |
Director |
– • – |
2022-06-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,270 |
63,894 |
0 |
- |
|
| CERE |
Cerevel Therapeutics Hold... |
Director |
– • – |
2023-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
3,282 |
47,853 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2021-11-15 |
4 |
A |
$258.43 |
$174,957 |
D/D |
677 |
677 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2022-01-18 |
4 |
A |
$247.07 |
$9,883 |
D/D |
40 |
720 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2022-02-22 |
4 |
A |
$239.13 |
$9,804 |
D/D |
41 |
761 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2022-03-21 |
4 |
A |
$289.64 |
$9,848 |
D/D |
34 |
798 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2022-04-18 |
4 |
A |
$298.82 |
$9,861 |
D/D |
33 |
831 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2022-05-16 |
4 |
A |
$299.38 |
$9,880 |
D/D |
33 |
864 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2022-06-21 |
4 |
A |
$297.34 |
$9,812 |
D/D |
33 |
900 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2022-07-18 |
4 |
A |
$321.77 |
$9,975 |
D/D |
31 |
931 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2022-08-15 |
4 |
A |
$313.94 |
$10,046 |
D/D |
32 |
963 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2022-09-19 |
4 |
A |
$305.09 |
$10,068 |
D/D |
33 |
999 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2022-10-17 |
4 |
A |
$332.76 |
$9,983 |
D/D |
30 |
1,029 |
0 |
- |
|
101 Records found
|
|
Page 1 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
